Related Experiment Video

Updated: Apr 23, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

9.4K

Genomic alterations as mediators of miRNA dysregulation in ovarian cancer

Casina W S Kan1, Viive M Howell, Michael A Hahn

  • 1Hormones and Cancer Group, Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia.

Genes, Chromosomes & Cancer
|October 4, 2014
PubMed

Insights

Genomic alterations like copy number variations influence microRNA (miRNA) expression in ovarian cancer. Understanding these changes in miRNA is key to improving ovarian cancer treatment and understanding its development.

Area of Science:

  • Genomics
  • Molecular Biology
  • Oncology

Background:

  • Ovarian cancer is a leading cause of cancer death in women globally.
  • Serous epithelial ovarian cancer (SEOC) is the most prevalent and aggressive subtype.
  • Genomic alterations and aberrant DNA damage signaling are characteristic of high-grade SEOC.

Purpose of the Study:

  • To review the influence of genomic alterations on microRNA (miRNA) expression in ovarian cancer.
  • To explore how copy number variations (CNVs) and single nucleotide polymorphisms affect miRNA regulation.
  • To understand the role of miRNA in regulating genes involved in DNA repair and genomic stability.

Main Methods:

  • Literature review focusing on genomic alterations in ovarian cancer.
  • Analysis of the impact of CNVs and single nucleotide polymorphisms on miRNA expression.
  • Examination of miRNA's role in regulating target genes, including those in DNA repair pathways.

Main Results:

  • Genomic alterations, including CNVs and single nucleotide polymorphisms, are common in ovarian cancer.
  • These alterations can significantly affect miRNA expression levels.
  • Dysregulated miRNAs can impact the expression of genes critical for DNA repair and genomic stability.

Conclusions:

  • Understanding miRNA dysregulation mechanisms in ovarian cancer is crucial.
  • Investigating the role of miRNA in ovarian cancer pathogenesis offers insights into potential therapeutic targets.
  • Further research into miRNA and genomic alterations can advance ovarian cancer treatment strategies.

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.7K
MicroRNAs01:22

MicroRNAs

9.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
57.8K